Bioprosthetic valve and preparation method thereof

Patent metadata

Field	Value
Publication number	US-12097113-B2
Application number	US-202017115812-A
Country	US
Kind code	B2
Filing date	Dec 9, 2020
Priority date	Apr 24, 2020
Publication date	Sep 24, 2024
Grant date	Sep 24, 2024

Abstract

A bioprosthetic valve and a preparation method thereof are provided. The bioprosthetic valve includes a stent and a functional biological tissue material attached to the stent. The functional biological tissue material is a biologicaltissue covalently bonded with an active group and a functional molecule or group. The method improves the anti-thrombosis and anti-calcification functions by covalently modifying the surface of a biological valve using an active group and a functional molecule or group with a substantial degree of grafting. The new bioprosthetic valve does not include aldehyde residues, exhibits excellent biocompatibility, optimal mechanical properties, high stability, and can meet the performance requirements of a biological valve delivered through a catheter.

First claim

What is claimed is:

1. A bioprosthetic valve, comprising a stent and a functional biological tissue material, wherein the functional biological tissue material is attached to the stent, and the functional biological tissue material is a biological tissue linked with an active group and a zwitterion by covalent bonds;
wherein the active group is one selected from the group consisting of acrylamide, methacrylamide, acrylate, methacrylate, and allyl group;
wherein the zwitterion is selected from the group consisting of sulfobetaine methacrylate (SBMA), carboxybetaine methacrylate (CBMA), and 2-methacryloyloxyethyl phosphocholine (MPC);
wherein, the functional biological tissue material is prepared by:
soaking the biological tissue in deionized water to obtain a first mixture, and adding the active group into the first mixture to obtain a second mixture, wherein a volume concentration of the active group in the second mixture is 3%-10%;
performing a reaction on the second mixture at room temperature for 12-36 hours to obtain a reacted biological tissue;
washing the reacted biological tissue to obtain a washed biological tissue;
soaking the washed biological tissue in a zwitterionic monomer solution overnight at 35° C.-40° C., wherein, a final concentration of the zwitterion is 20 mM-500 mM; and
adding an initiator for initiating a polymerization.

2. The bioprosthetic valve according to claim 1 , wherein, a structural formula of the zwitterion is shown as follows:

3. The bioprosthetic valve according to claim 1 , wherein, the active group is added to enable the volume concentration of the active group to be 4%, followed by reacting at room temperature for 24 hours.

4. The bioprosthetic valve according to claim 1 , wherein, the washed biological tissue is soaked in the zwitterionic monomer solution overnight at 37° C., wherein, the final concentration of the zwitterion is 500 mM.

5. The bioprosthetic valve according to claim 1 , wherein, the biological tissue is one selected from the group consisting of pericardium, aortic root, aortic valve, pulmonary root, pulmonary valve, tendon, ligament, skin, dura, peritoneum, blood vessel, pleura, diaphragm, mitral valve and tricuspid valve.

6. The bioprosthetic valve according to claim 1 , wherein, a weight of the zwitterion is 1%-30% of a dry weight of the functional biological tissue material.

7. The bioprosthetic valve according to claim 1 , wherein, the polymerization initiated by the initiator is conducted at a temperature of no more than 50° C.

8. A preparation method of the bioprosthetic valve according to claim 1 , comprising the following steps:
preparing the functional biological tissue material, cutting the functional biological tissue material to form a tissue valve leaflet assembly, and attaching the tissue valve leaflet assembly to the stent to obtain the bioprosthetic valve.

Assignees

• Univ Sichuan

Inventors

• Wang Yunbing
• Guo Gaoyang
• Yang Li

Classifications

• A61L2430/20

  for reconstruction of the heart, e.g. heart valves · CPC title

• A61L33/0023

  using a quaternized group or a protonated amine group of the substrate · CPC title

• A61L2300/208

  Quaternary ammonium compounds · CPC title

• A61L33/04

  Use of organic materials, e.g. acetylsalicylic acid · CPC title

• A61L31/005

  Ingredients of undetermined constitution or reaction products thereof · CPC title